← Evidence map

ArticleDrug design, development and therapy2022

An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism.

Qingjuan Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

54 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36304787